These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29463369)

  • 101. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
    Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
    Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Bromelain-decorated hybrid nanoparticles based on lactobionic acid-conjugated chitosan for in vitro anti-tumor study.
    Wei B; He L; Wang X; Yan GQ; Wang J; Tang R
    J Biomater Appl; 2017 Aug; 32(2):206-218. PubMed ID: 28618976
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
    Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
    [TBL] [Abstract][Full Text] [Related]  

  • 104. GA&HA-Modified Liposomes for Co-Delivery of Aprepitant and Curcumin to Inhibit Drug-Resistance and Metastasis of Hepatocellular Carcinoma.
    Li Y; Wu J; Lu Q; Liu X; Wen J; Qi X; Liu J; Lian B; Zhang B; Sun H; Tian G
    Int J Nanomedicine; 2022; 17():2559-2575. PubMed ID: 35698562
    [TBL] [Abstract][Full Text] [Related]  

  • 105. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
    Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
    Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.
    Ding XY; Hong CJ; Liu Y; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Zhang XN; Zhang Q
    Int J Nanomedicine; 2012; 7():1723-35. PubMed ID: 22619523
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Lactosylated Chitosan Nanoparticles Potentiate the Anticancer Effects of Telmisartan In Vitro and in a
    Nasr M; Kira AY; Saber S; Essa EA; El-Gizawy SA
    Mol Pharm; 2023 Sep; 20(9):4758-4769. PubMed ID: 37585079
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity.
    Xue H; Qin L; Zhang L; Li X; Wu F; Wang W; Wang C; Diao W; Jiang B; Lian B; Wu J; Bai J; Sun T; Zhao C; Qu M; Yu W; Wang Y; Gao Z
    Exp Ther Med; 2021 Oct; 22(4):1144. PubMed ID: 34471430
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Development of 11-DGA-3-
    Zhou L; Zou M; Zhu K; Ning S; Xia X
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31450608
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Synthesis of glycyrrhetinic acid-modified liposomes to deliver Murrayafoline A for treatment of hepatocellular carcinoma.
    Dinh CT; Vu HT; Phan QTH; Nguyen LP; Tran TQ; Van Tran D; Quy NN; Pham DTN; Nguyen DT
    J Mater Sci Mater Med; 2022 Oct; 33(10):72. PubMed ID: 36195780
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Thiolated polymer nanocarrier reinforced with glycyrrhetinic acid for targeted delivery of 5-fluorouracil in hepatocellular carcinoma.
    Bhat SS; Mukherjee D; Sukharamwala P; Dehuri R; Murali A; Teja BV
    Drug Deliv Transl Res; 2021 Oct; 11(5):2252-2269. PubMed ID: 33432520
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Apigenin-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma.
    Ganguly S; Dewanjee S; Sen R; Chattopadhyay D; Ganguly S; Gaonkar R; Debnath MC
    Colloids Surf B Biointerfaces; 2021 Aug; 204():111778. PubMed ID: 33915380
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Hepatocyte-targeted delivery using ph-sensitive liposomes loaded with lactosylnorcantharidin phospholipid complex: preparation, characterization, and therapeutic evaluation in vivo and in vitro.
    Qiao-ling Z; Yi Z; Min G; Di-jia Y; Xiao-feng Z; Yang L; Jing-yu X; Ying W; Zong-lin G; Kong-lang X; Ai-jun Z; Wei-liang C; Lin-sen S; Xue-nong Z; Qiang Z
    Curr Med Chem; 2012; 19(33):5754-63. PubMed ID: 22963621
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Two Zn(II) coordination polymers with anticancer drug norcantharidin as ligands for cancer chemotherapy.
    Wang J; Huang X; Li H; Yan D; Huang W
    Dalton Trans; 2022 Apr; 51(14):5624-5634. PubMed ID: 35319055
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Review targeted drug delivery systems for norcantharidin in cancer therapy.
    Zhai BT; Sun J; Shi YJ; Zhang XF; Zou JB; Cheng JX; Fan Y; Guo DY; Tian H
    J Nanobiotechnology; 2022 Dec; 20(1):509. PubMed ID: 36463199
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin.
    Liu Q; Sun H; Li X; Sheng H; Zhu L
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes.
    Kok SH; Hong CY; Kuo MY; Lee CH; Lee JJ; Lou IU; Lee MS; Hsiao M; Lin SK
    Oral Oncol; 2003 Jan; 39(1):19-26. PubMed ID: 12457717
    [TBL] [Abstract][Full Text] [Related]  

  • 118. A glycyrrhetinic acid-iridium(III) conjugate as a theranostic NIR probe for hepatocellular carcinoma with mitochondrial-targeting ability.
    Wang L; Wang X; Chen F; Song YQ; Nao SC; Chan DS; Wong CY; Wang W; Leung CH
    Eur J Med Chem; 2024 Jan; 264():115995. PubMed ID: 38043488
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
    Yi SN; Wass J; Vincent P; Iland H
    Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Nanoparticles based on glycyrrhetinic acid modified porphyrin for photodynamic therapy of cancer.
    Wang X; Wang P; Xue S; Zheng X; Xie Z; Chen G; Sun T
    Org Biomol Chem; 2018 Feb; 16(9):1591-1597. PubMed ID: 29445787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.